Botulinum toxin for refractory Raynaud's phenomenon: A “how to” guide for pediatric patients.

  • Published In: Pediatric Dermatology, 2023, v. 40, n. 3. P. 587 1 of 3

  • Database: Academic Search Ultimate 2 of 3

  • Authored By: Barry, Kelly K.; Reusch, Diana B.; Shahriari, Neda; Lonowski, Sarah; Dedeoglu, Fatma; Vleugels, Ruth Ann 3 of 3

Abstract

Raynaud's phenomenon describes symptoms caused by digital vascular spasm and is classically induced by cold exposure. Severe cases can result in ulceration, necrosis, and digital autoamputation. When standard and adjunctive medical therapies fail or are contraindicated, botulinum toxin A (BTX-A) is an effective treatment option that can be added to existing regimens and should be considered before utilizing rescue therapies associated with higher risk and often higher cost. This report describes our technique, highlights considerations relevant to pediatric patients, and provides photos and videos of the procedure performed on a 16-year-old girl. [ABSTRACT FROM AUTHOR]

Additional Information

  • Source:Pediatric Dermatology. 2023/05, Vol. 40, Issue 3, p587
  • Document Type:Article
  • Subject Area:Complementary and Alternative Medicine
  • Publication Date:2023
  • ISSN:0736-8046
  • DOI:10.1111/pde.15229
  • Accession Number:164691422
  • Copyright Statement:Copyright of Pediatric Dermatology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.